234
Participants
Start Date
September 1, 2015
Primary Completion Date
February 27, 2020
Study Completion Date
February 27, 2020
Data collection only
This registry is to capture high quality patient safety and effectiveness data on use of the Angiovac device for 3 separate, but overlapping conditions; a) Iliofemoral and Caval DVT, b) Right heart masses, and c) PE. The goal will be achieved by capturing a concise set of immediate and short-term functional and clinical outcome data for all patients who have the angiovac catheter deployed into the vascular system.
University of California, Los Angeles
OTHER